Saturday, July 11, 2026

Drug profile · INN

isosulfan blue

isosulfan blue (ISOSULFAN BLUE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: subcutaneous. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — isosulfan blue
US status
approved
Class
Route
SUBCUTANEOUS
Patents
0
Programs
0
Data quality
0.89

Quick answer

isosulfan blue (ISOSULFAN BLUE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: subcutaneous. Current US regulatory status: approved.

Key facts

INN isosulfan blue
Brand ISOSULFAN BLUE
Route SUBCUTANEOUS
Formulation SOLUTION

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is isosulfan blue?

isosulfan blue (ISOSULFAN BLUE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: subcutaneous. Current US regulatory status: approved.

What is the brand name for isosulfan blue?

ISOSULFAN BLUE is a marketed brand name for isosulfan blue. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of isosulfan blue?

isosulfan blue has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.